Home MEDP.AI

MEDP.AI

In operation
Series A+
Developer of Medical Artificial Intelligence Technology

Basic Information

MEDP.AI, established in January 2015 by senior scientists from Microsoft and Baidu, renowned professors from Peking University-affiliated hospitals and top universities, is a leading medical artificial intelligence company in China. It has received investments from globally recognized institutions such as U.S.-based Redpoint Ventures, Chongshan Yuanzhi Healthcare Fund with a medical background, Yilian Capital, Hongtai Fund, Han Xiaohong of Ciming Health Checkup, and 360. The company has developed multiple AI products including an AI underwriting system for health insurance, a disease risk prediction model system, an intelligent recognition system for medical receipts, an AI diagnostic system for retinal images, an intelligent auxiliary diagnosis system for chest CT scans, an intelligent auxiliary diagnosis system for chest X-rays, and an intelligent ECG analysis system. Additionally, it has developed robots and smart hardware devices for healthcare and elderly care (such as smart elderly care robots, butler robots, smart monitoring blankets, snore sleep monitoring devices, smart beds, smart wheelchairs, smart blood pressure monitors, smart glucose meters, and smart ECG machines), already serving hundreds of medical institutions.
MEDP.AI
Beijing,China
51~100 people
January 27, 2015
web@91paiyipai.com